Oxford Instruments shares slide 14% as tariffs weigh on first-half sales

Oxford Instruments PLC shares fell 14% after reporting an approximately 8% organic constant currency revenue decline and lower profits for the first half, primarily attributed to US tariffs and delayed customer orders impacting its high-margin Imaging and Analysis division. Despite strong growth in Advanced Technologies and a pick-up in overall order intake to just over 1% in Q2, the company projects a stronger second half, expecting full-year revenue and operating profit to be broadly in line with the previous year.

Analysis

Oxford Instruments PLC shares declined 14% following a report of weaker first-half trading, primarily driven by US tariffs and delayed customer orders. The company experienced an approximately 8% organic constant currency revenue decrease and lower profits for the six months ending September 30. This underperformance was notably impacted by slower demand for high-margin imaging products.

Tariff-related disruptions significantly affected the Imaging and Analysis division, which saw orders decline 11% in Q1 before stabilizing in Q2. Conversely, the Advanced Technologies segment demonstrated resilience with orders growing over 25% in both quarters, fueled by strong demand from the compound semiconductor market. Overall order intake for the first half increased just over 1%, recovering from a Q1 dip of 3% to a Q2 rise of nearly 6%.

Despite the challenging first half, Oxford Instruments anticipates a stronger second half, supported by seasonal trading patterns, cost savings at its Belfast imaging site, and new margin improvement initiatives. The company forecasts full-year revenue and operating profit to be broadly in line with the previous year's performance. CEO Richard Tyson acknowledged a "turbulent time" but expressed confidence in the company's proactive response.

Key Decisions for Investors

• Investors should closely monitor Oxford Instruments' execution on its second-half recovery plan, particularly the impact of cost savings and margin improvement measures.
• Evaluate the ongoing and potential future impact of US tariffs on the Imaging and Analysis division, and whether diversification into Advanced Technologies can sufficiently offset these headwinds.
• Re-assess the company's ability to achieve its full-year guidance of revenue and operating profit broadly in line with last year, given the significant first-half weakness.